Brian McNaughton, a professor of chemistry, biochemistry and molecular biology at Colorado State University, has received a $1.5 million grant from the National Institutes of Health to develop synthetic proteins that shut down disease-causing components in cells that do not respond well to traditional drug treatments.
link